Waldenstrom macroglobulinaemia involving extramedullary sites

Waldenstrom macroglobulinaemia is a B-cell neoplasm associated with a monoclonal IgM gammopathy. Although the clinical maifestations of Waldeström macroglobulinaemia may also occur with a variety of other B-cell lymphomas, the WHO classification now defines LPL/WM as a clinicopathological entity.

The bone marrow is almost always involved. There is hepatomegaly, lymphadenopathy or splenomegaly in 15-20% of patients. Hyperviscocity syndrome occurs in 15-20% of patients.

Histopathology and Immunohistochemistry of extramedullary sites

Where there are extramedullary tumour deposits, these vary in moth morphology and immunophenotype. In a study of 44 patients with extramedullary disease, the following were reported1:

Others have reported the clinical syndrome of Waldenstrom macroglobulinaemia in association with MZBCL2,3,4,5, SMZL6,

References

1Lin, P., C. Bueso-Ramos, et al. (2003). "Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients." Am J Surg Pathol 27(8): 1104-13.

2Allez, M., X. Mariette, et al. (1999). "Low-grade MALT lymphoma mimicking Waldenstrom's macroglobulinemia." Leukemia 13(3): 484-5.

3Berger, F., P. Felman, et al. (2000). "Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients." Blood 95(6): 1950-6.

4Nakata, M., Y. Matsuno, et al. (1997). "B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma." Int J Hematol 65(4): 405-11.

5Valdez, R., W. G. Finn, et al. (2001). "Waldenstrom macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases." Am J Clin Pathol 116(5): 683-90.

6Van Huyen, J. P., T. Molina, et al. (2000). "Splenic marginal zone lymphoma with or without plasmacytic differentiation." Am J Surg Pathol 24(12): 1581-92.

This page last revised 11.9.2003.

©SMUHT/PW Bishop